*Corresponding author:JunJun Yeh, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chiayi,Chia Nan University of Pharmacy and Science, Taiwan
Received:May 28, 2018; Published:June 08, 2018
To view the Full Article Peer-reviewed Article PDF
Asthma-chronic obstructive pulmonary syndrome (ACOS) is a disorder sharing the components of the asthma and COPD. The ACOS considered as a system inflammation disease. The cytokines such as interleukin-6 (IL-6)  and interleukin -10 (IL-10) associated with ACOS . The IL-6 enhancing the inflammation of lung and IL-10 attenuate the inflammation of lung [3,4].